Vertex Pharmaceuticals Inc.
0
0
0%

Statistics

Valuation metrics
Market cap
95.86B
Enterprise value
79.58B
Trailing P/E (ttm)
31.75
Forward P/E
PEG ratio
Price/Sales (ttm)
8.46
Price/Book (mrq)
6.64
Enterprise Value/Revenue
7.97
Enterprise Value/EBITDA
19.83
Overview
Shares outstanding
253.95M
Float
252.95M
Shares short
% Held by insiders
0.13%
% Held by institutions
97.44%
Average volume (10 days)
12
Average volume (90 days)
31
Price summary
52-Week low
313.80
52-Week high
474.60
52-Week change
-16.22
Beta
0.32
50-Day moving average
368.05
200-Day moving average
384.69
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
31.35%
Operating margin
40.27%
Operational effectiveness
Return on assets
12.04%
Return on equity
22.31%
Income statement
Revenue (ttm)
9.99B
Revenue per share (ttm)
45.68
Quarterly revenue growth (yoy)
11%
Gross profit (ttm)
5.26B
EBITDA
413.79M
Net income to common (ttm)
3.13B
Diluted EPS (ttm)
12.15
Quarterly earnings growth (yoy)
3.60%
Balance sheet
Total cash (mrq)
5.36B
Total cash per share (mrq)
24.78
Total debt (mrq)
1.56B
Total Debt/Equity (mrq)
10.59
Current ratio (mrq)
236.20%
Book value per share (mrq)
58.06
Cash flow
Cash flow statement
3.17B
Levered free cash flow (LFCF)
2.48B
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 59 minutes

05:00
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).